We are live on
!
Find out more
CA
Cornerstone Advisors Portfolio holdings
AUM
$3.04B
Turnover
28.46%
1-Year Est. Return
36.62%
This Fund
S&P 500
This Quarter
Est. Return
+7.58%
1 Year Est. Return
+36.62%
3 Year Est. Return
+108.19%
5 Year Est. Return
+137.76%
10 Year Est. Return
–
AUM
$1.39B
AUM Growth
+$562M
(+68%)
Cap. Flow
+$500M
Cap. Flow
% of AUM
36.03%
Top 10 Holdings %
Top 10 Hldgs %
25.39%
Holding
241
New
47
Increased
130
Reduced
26
Closed
20
Avg Time Held
1.4
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$23.3M |
| 2 |
Walmart Inc
WMT
|
+$21.9M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$21.4M |
| 4 |
Apple
AAPL
|
+$21.1M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Templeton Dragon Fund
TDF
|
+$4.17M |
| 2 |
CELG
Celgene Corp
CELG
|
+$3.49M |
| 3 |
Starbucks
SBUX
|
+$3.07M |
| 4 |
Cohen & Steers REIT and Preferred and Income Fund
RNP
|
+$2.52M |
| 5 |
American Tower
AMT
|
+$2.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 18.88% |
| 2 | Technology | 15.19% |
| 3 | Financials | 14.64% |
| 4 | Healthcare | 13.44% |
| 5 | Communication Services | 10.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Mexico Fund
MXF
$296M
| $5.19M | 0.37% |
318,266
+35,467
| +13% | +$571K |
2016 Q4
7 quarters
|
|
77
American Express
AXP
$212B
| $5.11M | 0.37% |
48,000
| – | – |
2017 Q4
3 quarters
|
|
|
AET
78
DELISTED
Aetna Inc
AET
| $5.07M | 0.37% |
25,000
+5,000
| +25% | +$977K |
2017 Q2
5 quarters
|
|
79
Micron Technology
MU
$994B
| $4.97M | 0.36% |
110,000
+65,000
| +144% | +$3.28M |
2018 Q1
2 quarters
|
|
80
Biogen
BIIB
$34.4B
| $4.95M | 0.36% |
+14,000
| New | +$4.82M |
2018 Q3
0 quarters
|
|
81
Bristol-Myers Squibb
BMY
$122B
| $4.84M | 0.35% |
+78,000
| New | +$4.63M |
2018 Q3
0 quarters
|
|
82
Deere & Co
DE
$173B
| $4.81M | 0.35% |
32,000
+16,000
| +100% | +$2.3M |
2016 Q3
8 quarters
|
|
83
US Bancorp
USB
$91.5B
| $4.75M | 0.34% |
90,000
| – | – |
2017 Q3
4 quarters
|
|
84
3M
MMM
$85B
| $4.64M | 0.33% |
26,312
-4,784
| -15% | -$824K |
2015 Q3
12 quarters
|
|
85
Cigna
CI
$79.9B
| $4.58M | 0.33% |
22,000
+8,000
| +57% | +$1.48M |
2013 Q2
21 quarters
|
|
86
Gabelli Healthcare & Wellness Trust
GRX
$147M
| $4.57M | 0.33% |
414,158
+9,368
| +2% | +$99.6K |
2016 Q4
7 quarters
|
|
87
NextEra Energy
NEE
$166B
| $4.53M | 0.33% |
108,000
| – | – |
2015 Q1
14 quarters
|
|
88
HCA Healthcare
HCA
$99.3B
| $4.45M | 0.32% |
32,000
+11,000
| +52% | +$1.37M |
2017 Q2
5 quarters
|
|
89
Cognizant
CTSH
$29.7B
| $4.4M | 0.32% |
57,000
+49,000
| +613% | +$3.83M |
2018 Q1
2 quarters
|
|
90
IBM
IBM
$219B
| $4.38M | 0.32% |
+30,334
| New | +$4.24M |
2018 Q3
0 quarters
|
|
91
Seven Hills Realty Trust
SEVN
$154M
| $4.35M | 0.31% |
241,961
+22,290
| +10% | +$412K |
2013 Q3
20 quarters
|
|
|
MSF
92
DELISTED
Morgan Stanley Emerging Mkts Fd
MSF
| $4.28M | 0.31% |
274,086
+63,743
| +30% | +$1.02M |
2017 Q1
6 quarters
|
|
93
Boston Scientific
BSX
$64.3B
| $4.27M | 0.31% |
111,000
+49,000
| +79% | +$1.71M |
2017 Q3
4 quarters
|
|
94
Japan Smaller Capitalization Fund
JOF
$337M
| $4.21M | 0.3% |
380,710
+96,079
| +34% | +$1.06M |
2016 Q1
10 quarters
|
|
95
Becton Dickinson
BDX
$52.2B
| $4.18M | 0.3% |
16,400
+5,125
| +45% | +$1.26M |
2017 Q2
5 quarters
|
|
96
NVIDIA
NVDA
$5.17T
| $4.13M | 0.3% |
+588,000
| New | +$3.82M |
2018 Q3
0 quarters
|
|
97
Danaher
DHR
$161B
| $4.13M | 0.3% |
42,864
+13,536
| +46% | +$1.23M |
2015 Q3
12 quarters
|
|
98
Exelon
EXC
$44.8B
| $4.06M | 0.29% |
+130,386
| New | +$4.01M |
2018 Q3
0 quarters
|
|
99
Baxter International
BAX
$13.1B
| $4.01M | 0.29% |
52,000
+24,000
| +86% | +$1.78M |
2016 Q4
7 quarters
|
|
100
Marriott International
MAR
$101B
| $3.96M | 0.29% |
30,000
+20,000
| +200% | +$2.55M |
2017 Q4
3 quarters
|
|
Similar funds
GFA
SL
JFGIW
Cornerstone Advisors's Q3 2018 Portfolio in Review
As of Q3 2018, Cornerstone Advisors held 241 positions worth $1.39B, up 68% from $827M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Cornerstone Advisors deployed $500M of net new capital in Q3 2018, opening 47 new positions and adding to 130 existing holdings. Its largest new stake was Pfizer: 604,996 shares worth $25.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 19% of assets, down from 22% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Templeton Dragon Fund, an estimated $4.17M trimmed.
- Cornerstone Advisors's largest Q3 2018 buy was Pfizer: 604,996 shares worth $25.3M.
- Cornerstone Advisors added most to Apple in Q3 2018, an estimated $21.1M increase.
- Cornerstone Advisors's biggest Q3 2018 reduction was Templeton Dragon Fund, cutting an estimated $4.17M.
- Cornerstone Advisors fully exited Celgene Corp in Q3 2018, selling an estimated $3.49M.
- Cornerstone Advisors's ten largest holdings make up 25% of its $1.39B portfolio in Q3 2018.
- Cornerstone Advisors opened 47 new positions and closed 20 in Q3 2018.
- Cornerstone Advisors's portfolio value rose 68% quarter-over-quarter to $1.39B.
Based on Cornerstone Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.